Journal of Medicinal Chemistry · 2011 · 57 citations · 31 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignMolecular PharmacologyStructure-activity RelationshipsDiabetes PharmacotherapyDrug-receptor InteractionsPotency OptimizationReceptor PharmacologyStructure-activity Relationship AnalysisAntidiabetic Drug TherapyChemical Structure-activity RelationshipsPeroxisome Proliferator-activated Receptor Gamma AgonismPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated Receptors
A series of benzimidazolone carboxylic acids and oxazolidinediones were designed and synthesized in search of selective PPARγ modulators (SPPARγMs) as potential therapeutic agents for the treatment of type II diabetes mellitus (T2DM) with improved safety profiles relative to rosiglitazone and pioglitazone, the currently marketed PPARγ full agonist drugs. Structure-activity relationships of these potent and highly selective SPPARγMs were studied with a focus on their unique profiles as partial agonists or modulators. A variety of methods, such as X-ray crystallographic analysis, PPARγ transactivation coactivator profiling, gene expression profiling, and mutagenesis studies, were employed to reveal the differential interactions of these new analogues with PPARγ receptor in comparison to full agonists. In rodent models of T2DM, benzimidazolone analogues such as (5R)-5-(3-{[3-(5-methoxybenzisoxazol-3-yl)benzimidazol-1-yl]methyl}phenyl)-5-methyloxazolidinedione (51) demonstrated efficacy equivalent to that of rosiglitazone. Side effects, such as fluid retention and heart weight gain associated with PPARγ full agonists, were diminished with 51 in comparison to rosiglitazone based on studies in two independent animal models.
31
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
Robert T. Nolte, G. Bruce Wisely, Stefan Westin et al. · Nature · 1998 · 1.9K citations
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
Joseph Torchia, David W. Rose, Juan Inostroza et al. · Nature · 1997 · 1.3K citations
Rosiglitazone-Associated Fractures in Type 2 Diabetes
Steven E. Kahn, Bernard Zinman, John M. Lachin et al. · Diabetes Care · 2008 · 537 citations · Full text
Philip J. Bailey, Chhabi Biswas, Catherine A. Cullinan et al. · Endocrinology · 1996 · 381 citations